Human TP53 polymorphism (rs1042522) modelled in mouse does not affect glucose metabolism and body composition

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Reiling, Erwin ^a   Speksnijder, Ewoud N ^b   Pronk, Amanda C M ^b   Van Den Berg, Sjoerd A A ^b,c   Neggers, Silvia J W ^b   Rietbroek, Ilma ^b   Van Steeg, Harry ^a,b   Dollé, Martijn E T ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PROTEIN P53;

AGING; ALLELE; ANIMAL; ANIMAL MODEL; BODY COMPOSITION; BODY WEIGHT; C57BL MOUSE; GENETICS; GLUCOSE TOLERANCE TEST; HUMAN; METABOLISM; MOUSE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE;

AGING; ALLELES; ANIMALS; BODY COMPOSITION; BODY WEIGHT; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84926500985     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04091     Document Type: Article

References (12)

1. Ko, L. J. & Prives, C. p53: puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).
2. Lozano, G. & Elledge, S. J. p53 sends nucleotides to repair DNA. Nature. 404, 24-25 (2000).
3. Orsted, D. D., Bojesen, S. E., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J. Exp. Med. 204, 1295-1301 (2007).
4. van Heemst, D. et al. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp. Gerontol. 40, 11-15 (2005).
5. Whibley, C., Pharoah, P. D. & Hollstein, M. p53 polymorphisms: cancer implications. Nat. Rev. Cancer. 9, 95-107 (2009).
6. Thomas, M. et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell Biol. 19, 1092-1100 (1999).
7. Zhu, F. et al. Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res. 70, 5851-5859 (2010).
8. Reiling, E. et al. Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time. European journal of human genetics: EJHG 20, 696-700, doi:10.1038/ejhg.2011.240 (2012).
9. Gaulton, K. J. et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 57, 3136-3144, doi:10.2337/db07-1731 (2008).
10. Pangilinan, F. et al. Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population. American journal of medical genetics. Part A 146A, 2617-2625, doi:10.1002/ajmg.a.32504 (2008).
11. Dumont, P., Leu, J. I., Della Pietra, A. C. 3rd, George, D. L. & Murphy, M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33, 357-365, doi:10.1038/ng1093 (2003).
12. Thomas, M. et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19, 1092-1100 (1999).